NASDAQ:OFIX - Nasdaq - US68752M1080 - Common Stock - Currency: USD
NASDAQ:OFIX (5/21/2025, 1:33:50 PM)
11.58
-0.41 (-3.42%)
The current stock price of OFIX is 11.58 USD. In the past month the price decreased by -8.75%. In the past year, price decreased by -19.48%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.04 | 232.45B | ||
ISRG | INTUITIVE SURGICAL INC | 71.92 | 196.93B | ||
BSX | BOSTON SCIENTIFIC CORP | 39.06 | 156.00B | ||
SYK | STRYKER CORP | 30.42 | 145.51B | ||
MDT | MEDTRONIC PLC | 16 | 109.55B | ||
BDX | BECTON DICKINSON AND CO | 12.35 | 49.97B | ||
EW | EDWARDS LIFESCIENCES CORP | 29.13 | 44.52B | ||
IDXX | IDEXX LABORATORIES INC | 44.16 | 40.79B | ||
RMD | RESMED INC | 27.03 | 35.99B | ||
DXCM | DEXCOM INC | 51.68 | 33.44B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 15.16 | 31.93B | ||
STE | STERIS PLC | 26.47 | 24.29B |
Orthofix Medical, Inc. engages in the provision of medical devices. The company is headquartered in Lewisville, Texas and currently employs 1,616 full-time employees. The firm offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. The Company’s Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The segment provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. The company offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures.
ORTHOFIX MEDICAL INC
3451 Plano Pkwy
Lewisville TEXAS 75056 US
CEO: Jon Serbousek
Employees: 1616
Phone: 12149372000
The current stock price of OFIX is 11.58 USD. The price decreased by -3.42% in the last trading session.
The exchange symbol of ORTHOFIX MEDICAL INC is OFIX and it is listed on the Nasdaq exchange.
OFIX stock is listed on the Nasdaq exchange.
12 analysts have analysed OFIX and the average price target is 24.79 USD. This implies a price increase of 114.04% is expected in the next year compared to the current price of 11.58. Check the ORTHOFIX MEDICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ORTHOFIX MEDICAL INC (OFIX) has a market capitalization of 451.85M USD. This makes OFIX a Small Cap stock.
ORTHOFIX MEDICAL INC (OFIX) currently has 1616 employees.
ORTHOFIX MEDICAL INC (OFIX) has a support level at 11.98 and a resistance level at 12.15. Check the full technical report for a detailed analysis of OFIX support and resistance levels.
The Revenue of ORTHOFIX MEDICAL INC (OFIX) is expected to grow by 2.35% in the next year. Check the estimates tab for more information on the OFIX EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
OFIX does not pay a dividend.
ORTHOFIX MEDICAL INC (OFIX) will report earnings on 2025-08-04, after the market close.
The PE ratio for ORTHOFIX MEDICAL INC (OFIX) is 193. This is based on the reported non-GAAP earnings per share of 0.06 and the current share price of 11.58 USD. Check the full fundamental report for a full analysis of the valuation metrics for OFIX.
The outstanding short interest for ORTHOFIX MEDICAL INC (OFIX) is 2.28% of its float. Check the ownership tab for more information on the OFIX short interest.
ChartMill assigns a fundamental rating of 3 / 10 to OFIX. OFIX has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months OFIX reported a non-GAAP Earnings per Share(EPS) of 0.06. The EPS increased by 400% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -14.1% | ||
ROE | -25.04% | ||
Debt/Equity | 0.35 |
ChartMill assigns a Buy % Consensus number of 82% to OFIX. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of 1583% and a revenue growth 2.35% for OFIX